These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21394570)

  • 1. Effects of a pharmacotherapy follow-up in community pharmacies on type 2 diabetes patients in Brazil.
    Correr CJ; Melchiors AC; Fernandez-Llimos F; Pontarolo R
    Int J Clin Pharm; 2011 Apr; 33(2):273-80. PubMed ID: 21394570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pharmacotherapy follow-up program in patients with type-2 diabetes in community pharmacies in Spain.
    Fornos JA; Andrés NF; Andrés JC; Guerra MM; Egea B
    Pharm World Sci; 2006 Apr; 28(2):65-72. PubMed ID: 16791717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of a community pharmacist intervention in diabetes care: a randomized controlled trial.
    Mehuys E; Van Bortel L; De Bolle L; Van Tongelen I; Annemans L; Remon JP; Giri M
    J Clin Pharm Ther; 2011 Oct; 36(5):602-13. PubMed ID: 21143256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved Glycemic Control With Minimal Change in Medication Regimen Complexity in a Pharmacist-Endocrinologist Diabetes Intense Medical Management (DIMM) "Tune Up" Clinic.
    Morello CM; Rotunno T; Khoan J; Hirsch JD
    Ann Pharmacother; 2018 Nov; 52(11):1091-1097. PubMed ID: 29775079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmaceutical care of patients with type 2 diabetes mellitus.
    Borges AP; Guidoni CM; Ferreira LD; de Freitas O; Pereira LR
    Pharm World Sci; 2010 Dec; 32(6):730-6. PubMed ID: 20734138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study investigating the impact of pharmacist involvement on the outcomes of diabetes medication therapy adherence program Malaysia.
    Lim PC; Lim K; Embee ZC; Hassali MA; Thiagarajan A; Khan TM
    Pak J Pharm Sci; 2016 Mar; 29(2):595-601. PubMed ID: 27087103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of diabetes indices of care by a short pharmaceutical care program.
    Turnacilar M; Sancar M; Apikoglu-Rabus S; Hursitoglu M; Izzettin FV
    Pharm World Sci; 2009 Dec; 31(6):689-95. PubMed ID: 19777365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A retrospective analysis of the fasting plasma glucose and glycosylated hemoglobin and pharmacotherapy change patterns among type 2 diabetes mellitus patients.
    Davidson J; Koro C; Arondekar B; Lee BH; Fedder D
    Clin Ther; 2008 Feb; 30(2):287-93. PubMed ID: 18343267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacist-Managed Diabetes Center Interventions Ensure Quality and Safety in Elderly Patients.
    Twigg G; Motsko J; Thomas J; David T
    Consult Pharm; 2017 May; 32(5):299-310. PubMed ID: 28483010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication use and disease management of type 2 diabetes in Belgium.
    Mehuys E; De Bolle L; Van Bortel L; Annemans L; Van Tongelen I; Remon JP; Giri M
    Pharm World Sci; 2008 Jan; 30(1):51-6. PubMed ID: 17588213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of Dietary Glycaemic Index on Glycaemia in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Ojo O; Ojo OO; Adebowale F; Wang XH
    Nutrients; 2018 Mar; 10(3):. PubMed ID: 29562676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community Pharmacists Assisting in Total Cardiovascular Health (CPATCH): A Cluster-Randomized, Controlled Trial Testing a Focused Adherence Strategy Involving Community Pharmacies.
    Blackburn DF; Evans CD; Eurich DT; Mansell KD; Jorgenson DJ; Taylor JG; Semchuk WM; Shevchuk YM; Remillard AJ; Tran DA; Champagne AP
    Pharmacotherapy; 2016 Oct; 36(10):1055-1064. PubMed ID: 27581815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of an mHealth-enabled hierarchical diabetes management intervention in primary care in China (ROADMAP): A cluster randomized trial.
    Jia W; Zhang P; Zhu D; Duolikun N; Li H; Bao Y; Li X;
    PLoS Med; 2021 Sep; 18(9):e1003754. PubMed ID: 34547030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Hispanic Diabetes Management Program: Impact of community pharmacists on clinical outcomes.
    Oyetayo OO; James C; Martinez A; Roberson K; Talbert RL
    J Am Pharm Assoc (2003); 2011; 51(5):623-6. PubMed ID: 21896461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Economic evaluation of pharmacotherapeutic follow-up in type 2 diabetes mellitus patients in community pharmacies].
    Correr CJ; Pontarolo R; Wiens A; Rossignoli P; Melchiors AC; Radominski R; Fernandez-Llimós F
    Arq Bras Endocrinol Metabol; 2009 Oct; 53(7):825-33. PubMed ID: 19942984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseline and 1-year interim follow-up assessment of Japanese patients initiating insulin therapy who were enrolled in the cardiovascular risk evaluation in people with type 2 diabetes on insulin therapy study: an international, multicenter, observational study.
    Kawamori R; Node K; Hanafusa T; Atsumi Y; Naito Y; Oka Y
    Cardiovasc Diabetol; 2013 Sep; 12():131. PubMed ID: 24011395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmaceutical care of elderly patients with poorly controlled type 2 diabetes mellitus: a randomized controlled trial.
    Chen JH; Ou HT; Lin TC; Lai EC; Kao YH
    Int J Clin Pharm; 2016 Feb; 38(1):88-95. PubMed ID: 26499503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safe and effective use of medicines for patients with type 2 diabetes - A randomized controlled trial of two interventions delivered by local pharmacies.
    Kjeldsen LJ; Bjerrum L; Dam P; Larsen BO; Rossing C; Søndergaard B; Herborg H
    Res Social Adm Pharm; 2015; 11(1):47-62. PubMed ID: 24798710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of a Female Community Health Volunteer-Delivered Intervention in Reducing Blood Glucose Among Adults With Type 2 Diabetes: An Open-Label, Cluster Randomized Clinical Trial.
    Gyawali B; Sharma R; Mishra SR; Neupane D; Vaidya A; Sandbæk A; Kallestrup P
    JAMA Netw Open; 2021 Feb; 4(2):e2035799. PubMed ID: 33523189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of acarbose on carotid intima-media thickness in patients with newly diagnosed impaired glucose tolerance or mild type 2 diabetes mellitus: A one-year, prospective, randomized, open-label, parallel-group study in Japanese adults with established coronary artery disease.
    Koyasu M; Ishii H; Watarai M; Takemoto K; Inden Y; Takeshita K; Amano T; Yoshikawa D; Matsubara T; Murohara T
    Clin Ther; 2010 Aug; 32(9):1610-7. PubMed ID: 20974318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.